Associated Papers
Epidermal Growth Factor Receptor Kinase Domain Duplication in Lung Adenocarcinoma with Sensitive Response to Afatinib: A Case Report and Literature Review.
Chen S et al.
Lung Cancer (auckland, N.z.), 2025
Durable response to EGFR tyrosine kinase inhibitors in a patient with non-small cell lung cancer harboring an EGFR kinase domain duplication.
Hirokawa E et al.
Thoracic Cancer, 2021
Select a paper to view details